Arrowhead Pharmaceuticals Inc (ARWR) earnings · rev $829.4M
These earnings events as JSON? API free 100/dayArrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
This ARWR earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was -$1.6M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
When the next ARWR 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. An earnings headline that ignores that move is noise.
Not investment advice. Full ARWR research stays on the stock page; the tape stays on the quote page.
ARWR earnings FAQ
What are ARWR's latest revenue and net income?
Latest cached Arrowhead Pharmaceuticals Inc (ARWR) revenue for Sep 30, 2025 was $829.4M. Net income was -$1.6M. Statements: https://lician.com/financials/arwr
What is ARWR's latest diluted EPS?
Latest cached Arrowhead Pharmaceuticals Inc (ARWR) diluted EPS for Sep 30, 2025 was -$0.01.
What period does the latest ARWR earnings print cover?
The latest cached Arrowhead Pharmaceuticals Inc (ARWR) earnings print covers Sep 30, 2025. The prior cached period on this page is Sep 30, 2024.
How did ARWR revenue change from the prior cached period?
Cached Arrowhead Pharmaceuticals Inc (ARWR) revenue was up 23258.2% from $3.6M (Sep 30, 2024) to $829.4M (Sep 30, 2025). Statements: https://lician.com/financials/arwr
Where are ARWR earnings listed?
Cached earnings facts for Arrowhead Pharmaceuticals Inc (ARWR) are listed at https://lician.com/earnings/arwr. Statements: https://lician.com/financials/arwr
Not investment advice.